The Week Ahead: Hom...
Health Care: Health Services
Harvard Bioscience Inc. (HBIO: NASDAQ)
$5.17 -0.03 | -0.58%
05/20/13 - 01:31 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 5.20 |
| 52 Week High | 6.15 |
| 52 Week Low | 3.45 |
| Avg. Daily Vol. (Mil) | 0.18 |
| Beta (3 year) | 1.02 |
| Share Related Items | |
| Mkt Cap (Mil) | 156.32 |
| Shares Out (Mil) | 30.06 |
| Float (Mil) | 25.48 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.20 |
| Current Ratio | 4.70 |
| LT Debt/ Equity | 0.11 |
| Total Debt / Equity | 0.14 |
| Valuation Ratios | |
| Price Earnings | 65.00 |
| Price/Sales | 1.44 |
| Price/Book | 1.50 |
| Price/Cash Flow | 23.30 |
| Per Share Data | |
| Earnings | 0.08 |
| Sales | 3.62 |
| Book Value | 3.47 |
| Cash Flow | 0.22 |
| Business Summary | |
|---|---|
| Harvard Bioscience, Inc. is a developer, manufacturer and marketer of apparatus and scientific instruments, used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. | |
| General Information | |
| 84 October Hill Road
Holliston, MA 01746 |
|
| www.harvardbioscience.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 398 | |
| CEO: David Green | |
| Short Interest | |
| Current Month (Mil) | 0.75 |
| Previous Month (Mil) | 0.63 |
| Short Interest Ratio (Days) | 4.70 |
| Management Effectiveness | |
| Return on Equity | 2.40 |
| Return on Assets | 1.80 |
| Return on Investments | 2.10 |
| Profitability | |
| Gross Margin | 48.40 |
| EBIT Margin | 1.60 |
| Profit Margin | 2.30 |
Portfolios with HBIO
- Portfolio NameUser Type
- UserJoePa66
- Contributor5 Stocks Under-$10 Setting ...
- ContributorTheStreet Ratings Top-Rated...
- UserMike's Safe Play Portfolio
- UserRocket Stocks For The Week ...
- UserRocket Stocks For The Week ...
- UserRocket Stocks For The Week ...
- Userjim c's Portfolio 1
- UserRocket Stocks For The Week ...
- UserTom's Stuff
Latest HBIO Headlines from TheStreet
- The Five Dumbest Things on Wall Street: April 12
04.12.13 | 05:04 am - HBIO Announces Postponement Of The IPO For Harvard Apparatus Regenerative Technology, Inc. 04.09.13 | 05:04 pm
- HBIO Announces Filing Of Request For Acceleration Of Effectiveness For Harvard Apparatus Regenerative Technology, Inc.'s IPO Registration Statement 04.02.13 | 07:04 am
- Harvard Bioscience, Inc. Announces Receipt Of Private Letter Ruling And Affirms Plan To Spin-Off Harvard Apparatus Regenerative Technology, Inc. Following Its Initial Public Offering 03.25.13 | 07:03 am
- HBIO Reports Fourth Quarter 2012 Results 02.28.13 | 07:02 am
- Harvard Bioscience, Inc. Schedules Fourth Quarter 2012 Conference Call For February 28, 2013 02.25.13 | 03:02 pm
- TheStreet Ratings Top 10 Rating Changes 01.14.13 | 10:01 am
- Harvard Bioscience Inc. Stock Upgraded (HBIO) 01.10.13 | 04:01 am
- Harvard Bioscience, Inc. Announces Filing Of IPO Registration Statement For Harvard Apparatus Regenerative Technology, Inc. 12.11.12 | 04:12 pm
- Harvard Bioscience Inc. Stock Downgraded (HBIO) 11.20.12 | 04:11 am
Press Releases for HBIO
- SeeThruEquity Launches First Free Institutional Equity Research Platform - Business Wire 06.23.11 | 10:06 am
- Cellectis Grants Harvard Bioscience A License To CytoPulse Electroporation Instruments - PR Newswire 12.02.10 | 02:12 am
Partner Headlines for HBIO
- Investment Potential In Electroporation Companies - Seeking Alpha 07.17.12 | 09:07 am
- 16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money - Seeking Alpha 09.16.11 | 05:09 pm
- 5 Likely Additions to the Russell 2000 - Seeking Alpha 05.04.11 | 08:05 am
